ERK1/2 inhibitor 4
ERK1/2 inhibitor 5 is a potent inhibitor of ERK1/2. Mitogen-activated protein kinase (MAPK) plays an extremely important role in the signal transduction pathway, and extracellular signal regulated kinase (ERK) is a member of the MAPK family. ERK1/2 inhibitor 5 has the potential for the research or prevention of cancer, inflammation or other proliferative diseases (extracted from patent WO2020238776A1) [1].
Product Specifications
CAS Number
[2490396-99-9]
UNSPSC
12352005
Target
ERK
Type
Reference compound
Related Pathways
MAPK/ERK Pathway; Stem Cell/Wnt
Applications
COVID-19-immunoregulation
Field of Research
Cancer; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/erk1-2-inhibitor-4.html
Solubility
10 mM in DMSO
Smiles
O=C1C2=C(CCN1[C@H](C)C(N[C@@H](C3=CC(OC)=CC(F)=C3)CO)=O)SC(C4=NC(NC5CCOCC5)=NC=C4Cl)=C2
Molecular Formula
C28H31ClFN5O5S
Molecular Weight
604.09
References & Citations
[1]Xin Li, et al. Thienoheterocyclic derivatives, their preparation method and their application in medicine. Patent WO2020192750A1.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
PKM2, NT (E131) (PKM, OIP3, PK2, PK3, PKM2, Pyruvate kinase isozymes M1/M2, Cytosolic thyroid hormone-binding protein, Opa-interacting protein 3, Pyruvate kinase 2/3, Pyruvate kinase muscle isozyme, Thyroid hormone-binding protein 1, Tumor M2-PK, p58) (FITC) discontinued
